Notice: Passwords are now case-sensitive
Forgot your password? Register a new account

Connections

Groups

Community Requests

CompPharma Reports Progress on Opioids, Compounds

By Elaine Goodman (medical/business Reporter)

Wednesday, November 15, 2017 | 562 | 3 | 0 min read

Three years ago, workers’ comp payers cited three key drivers to drug spend: opioids, physician-dispensed drugs and compounded medications. Now, the latest edition of an annual report from CompPharma shows that progress has been made on at least two of those issues. The CompPharma report found that opioid spending was down 13.3% in 2016. And use of compounds plummeted 40%. Overall, drug spending was down 11% in 2016. That brings the total decrease in drug spend to 22% over the last seven years, according to CompPharma, a consortium of workers’ comp pharmacy benefit managers that ...

Purchase this story for only $9.16!Add to Cart


For access to all of our articles, check out our subscription options.

Comments

Yvonne Guibert Nov 15, 2017 11:04 AM

Great article. Good to hear about the improvements in terms of decrease in Rx / opioid spending. Physician dispensing / physicians looking for ways to make dollars in the WC system seems to be a persistent issue.

0 0

Related Articles